首页> 外文期刊>Journal of cancer education: the official journal of the American Association for Cancer Education >Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening
【24h】

Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening

机译:初级保健提供者预期使用决策辅助前列腺癌筛查的前列腺特异性抗原试验

获取原文
获取原文并翻译 | 示例
           

摘要

Decision aids are tools intended to help people weigh the benefits and harms of a health decision. We examined primary care providers' perspective on use of decision aids and explored whether providers' beliefs and interest in use of a decision aid was associated with offering the prostate-specific antigen (PSA) test for early detection of prostate cancer. Data were obtained from 2016 DocStyles, an annual, web-based survey of U.S. healthcare professionals including primary care physicians (n = 1003) and nurse practitioners (n = 253). We found that the majority of primary care providers reported not using (patient) decision aids for prostate cancer screening, but were interested in learning about and incorporating these tools in their practice. Given the potential of decision aids to guide in informed decision-making, there is an opportunity for evaluating existing decision aids for prostate cancer screening for clinical use.
机译:决策辅助工具是旨在帮助人们权衡健康决策的益处和危害的工具。 我们研究了初级护理提供商对使用决策援助的看法,并探讨了提供者的信仰和使用决策援助的兴趣与提供前列腺特异性抗原(PSA)测试是否早期检测前列腺癌。 数据是从2016年的DocStyles获得的,年度基于网络的美国医疗保健专业人员(包括初级保健医生(n = 1003)和护士从业者(n = 253)。 我们发现,大多数初级护理提供者报告未使用(患者)前列腺癌筛查的决策助剂,但有兴趣在他们的实践中学习和纳入这些工具。 鉴于决策援助的潜力指导在知情决策中,有机会评估前列腺癌筛查的现有决策助剂进行临床用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号